A neuroendocrine-based regulatory fatigue model

Biological Research for Nursing

Volumn 6, Issue 2, 2004, Pages 141-150

  Payne, Judith K ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Fatigue mechanisms; Interventions; Metabolic; Model; Neuroendocrine; Neurotransmitters

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

BIOLOGICAL MODEL; CIRCADIAN RHYTHM; FATIGUE; HOMEOSTASIS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NEUROSECRETION; PATHOPHYSIOLOGY; REVIEW;

CIRCADIAN RHYTHM; FATIGUE; HOMEOSTASIS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, BIOLOGICAL; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTER AGENTS; PITUITARY-ADRENAL SYSTEM;

EID: 6944245063     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800404268280     Document Type: Review

References (53)

1. Aistars J. 1987. Fatigue in the cancer patient: a conceptual approach to a clinical problem. Oncol Nurs Forum 14:25-30.
2. Andersen B. 2002. Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 70:590-610.
3. Barsevick A. 2001. There's more to fatigue than anemia. Oncology Times, January, p 22-5.
4. Berger A, Farr L. 1999. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 26:1663-71.
5. Berger A, Higginbotham P. 2000. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum 27:1443-8.
6. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. 1998. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689-96.
7. Carpenter J, Andrykowski MA. 1998. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45:5-13.
8. Carpenter J, Elam J, Ridner S, Carney P, Cherry G, Cucullu H. 2004. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31:591-598.
9. Caudell KA. 2000. Psychoneuroimmunology: foundations for mind-body interactions. In: Winningham W, Barton-Burke M, editors. Fatigue in cancer: a multidimensional approach. Boston (MA): Jones & Bartlett. p 123-49.
10. Cleare AJ, Beam J, Allain T, McGregor A, Wessely S, Murray RM, O'Keane VO. 1995. Contrasting neuroendocrine responses and chronic fatigue syndrome. J Affect Disord 35:283-289.
11. Cleare AJ, Miell J, Hea E, Sookdeo S, Young L, Malhi GS. O'Keane V. 2001. Hypothalmo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 86:3545-54.
12. Cleeland C, Bennett G, Dantzer R, Dougherty P, Dunn A, Meyers C, Miller, A.H., Payne, R., Reuben, J.M., Wang, X.S. and others. 2003. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? Cancer 97:2919-25.
13. Davis JM, Alderson NL, Welsh RE. 2000. Serotonin and central nervous system fatigue: nutritional considerations. Am J Clin Nutr 72(2 Suppl):573S-578S.
14. Demitrack MA. 1997. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 31:69-82.
15. Demitrack MA, Dale JK, Straus SE, Laue L., Listwak SJ, Kruesi M, Chrousos GP, Gold PW. 1991. Evidence for impaired activation of the hypothalamic- pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73:1224-34.
16. Ganong WF. 1999. Review of medical physiology. 19th ed. Stamford (CN): Appleton & Lange.
17. Groenwald S, Frogge M, Goodman M, Yarbo SL. 1998. Cancer nursing principles & practice. 4th ed. Boston: Jones & Bartlett.
18. Haylock P, Hart LK. 1979. Fatigue in patients receiving localized radiation. Cancer Nurs 2:461-7.
19. Howlett TA, Tomlin S, Ngahfoong L, Rees LH, Bullen BA, Skrinar OS, McArthur JW. 1984. Release of B-endorphin and Metenkephalin during exercise in normal women: response to training. BMJ 288:1950-1952.
20. Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, Gu YJ, Huang CH, Li YB, Jiang CL and others. 2000. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A 97:9543-8.
21. Irvine DM, Vincent L, Bubela N, Thompson L. 1994. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. Cancer Nurs 17:367-78.
22. Irvine DM, Vincent L, Bubela N, Thompson L, Graydon J. 1991. A critical appraisal of the research literature investigating fatigue in the cancer patient. Cancer Nurs 14:188-99.
23. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. 1999. Fatigue in women receiving adjuvant chemotherapy for breast cancer characteristics, course, and correlates. J Pain Symptom Manage 18:233-42.
24. Jones TH, Wadler S, Hupart K. 1998. Endocrine-mediated mechanisms of fatigue during treatment with Interferon-x. Semin Oncol 25(Suppl 1):54-63.
25. Kiecolt-Glaser JK, Carner W, Speicher C, Penn GM, Holliday J, Glaser R. 1984. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med 46:7-14.
26. Lesage P, Portenoy RK. 2002. Management of fatigue in the cancer patient. Oncology 16:373-81.
27. Lewin D. 1996. Researchers cycle down the path to elucidating melatonin's rhythms. J NIH Res 8:45-9.
28. Mock V. 2000. NCCN practice guidelines for cancer-related fatigue. NCCN Proceedings. Oncology 14:151-61.
29. Nail LM, Winningham ML. 1995. Fatigue and weakness in cancer patients: the symptom experience. Semin Oncol Nurs 11:272-8.
30. Neri B, de Leonardis V Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G. 1998. Melatonin as biological response modifier in cancer patients. Anticancer Res 18:1329-32.
31. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y. 2000. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 8:215-22.
32. Parker AJ, Wessely S, Cleare AJ. 2001. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 31:1331-45.
33. Payne J. 2002. The trajectory of fatigue in adult breast and ovarian cancer patients receiving chemotherapy. Oncol Nurs Forum 29:1334-40.
34. Payne J, Piper B, Rabinowitz I, Thompson T. 2003. Biomarkers, sleep and fatigue characteristics in women with breast cancer [Abstract]. Proceedings of the Seventh National Conference on Cancer Nursing Research, 6-8 February, San Diego (CA).
35. Piper BF, Dibble SL, Dodd MJ, Wiess MC, Slaughter RE, Paul SM. 1998. The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677-84.
36. Piper BF, Lindsey AM, Dodd MJ. 1987. Fatigue mechanisms in cancer patients: developing nursing theory. Oncol Nurs Forum 14:17-23.
37. Raab C, Weidmann E, Schmidt A, Bergmann L, Badenhoop K, Usadel K, Haak T. 1999. The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 50:37-44.
38. Ream E, Richardson A. 1999. From theory to practice: designing interventions to reduce fatigue in patients with cancer. Oncol Nurs Forum 26:1295-303.
39. Richardson A. 1995. Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20-32.
40. Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL. 2002. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 10:329-36.
41. Ryden M. 1977. Energy: a crucial consideration in the nursing process. Nurs Forum 6:71-82.
42. Schwartz A. 2000. Daily fatigue patterns and effect of exercise in women with breast cancer receiving chemotherapy. Cancer Practice 1:16-24.
43. Schwartz A, Mori M, Gao R, Nail L, King ME. 2001. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 33:718-23.
44. Tiesinga L, Dassen T, Halfens R, van den Heuvel W. 1999. Factors related to fatigue: priority of interventions to reduce or eliminate fatigue and the exploration of a multidisciplinary research model for further study of fatigue. Int J Nurs Stud 36:265-89.
45. Tortora G, Grabowski S. 1996. Principles of anatomy and physiology. New York: Biological Sciences Textbooks.
46. Touitou Y, Haus E. 1994. Biologic rhythms in clinical and laboratory medicine. Paris: Springer Verlag.
47. Touitou Y Levi F, Bogdan A, Benavides M, Bailleul F, Misset JL. 1995. Rhythm alterations in patients with metastatic breast cancer and poor prognostic factors. J Cancer Res Clin Oncol 121:181-8.
48. Visovsky C, Schneider S. 2003. Cancer-related fatigue. Online J Issues Nursing. Retrieved 29 September 2003, from www.nursingworld.org/ojin/hirsh/ topic3/tpc3_1.htm
49. Vogelzang NJ, Breitbart W, Cella D, Curt G, Groopman J, Horning S, Itri LM, Johnson DH, Scherr LL, Portnoy RK. 1997. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34(Suppl 2):4-12.
50. Winningham M. 1995. Fatigue: the missing link to quality of life. Qual Life Res 4:2-6.
51. Winningham M, Barton-Burke M, editors. 2000. Fatigue in cancer: a multidimensional approach. Boston (MA): Jones & Bartlett.
52. Winningham M, Nail L, Burke M, Brophy L, Cimprich B, Jones L, Pickard-Holley S, Rhodes V, St. Pierre B, Beck S and others. 1994. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21:23-36.
53. Winningham ML. 2000. The foundations of energetics: fatigue, fuel, and functioning. In: Winningham ML, Barton-Burke M, editors. Fatigue in cancer. Boston (MA): Jones and Bartlett. p 31-54.